Biological: Mapping receptors in the brain

12-Jul-2013

Scientists in the UK and Germany have developed and tested new compounds that enhance the contrast of magnetic resonance imaging (MRI) scans of the brain to show the location of receptor molecules linked to serious neurological disorders in real time.

In research published in Chemical Science, they describe the synthesis of a series of novel MRI contrast agents that can pinpoint and bind reversibly to N-methyl-D-aspartate (NMDA) receptors in vitro.

NMDA receptors are glutamate receptors that play a key role in memory, learning and neurotransmission. Misregulation and overstimulation of NMDA receptors has been associated with Parkinson’s and Alzheimer’s diseases.

Using two independent methods, MRI and optical microscopy, the scientists demonstrate that their new molecules bind selectively to NMDA receptors on cell surfaces in the brain and that this binding is reversible in model systems. This shows that the probes can respond to changing glutamate levels during actual neural events, allowing the scientists to effectively map the location of these receptors on brain cell surfaces in real time.

Original publication:

N Sim et al, Chem. Sci., 2013.

Facts, background information, dossiers
  • neurotransmission
  • Durham University
More about Durham University
  • News

    Moving the MRI goalposts

    Scientists in the UK have developed a new class of MRI (magnetic resonance imaging) agents that promise to deliver clearer images more quickly. Chemical shifts from proton NMR normally fall between 0-12ppm, but water and fat resonate at 4.7 and 1.3ppm respectively, causing noise that can ov ... more

    Scientists get £ 2 million to develop cancer imaging

    Scientists are set for a cash boost to develop the latest cancer imaging technologies. Cancer experts at Durham and Newcastle universities will receive more than £2 million over the next five years. The money is part of a £50 million nationwide initiative to establish the UK as a world le ... more

More about Royal Society of Chemistry
  • News

    Therapeutic screening for Alzheimer’s disease

    Scientists in Canada and the United States have developed a chip sensor for monitoring how drug candidates alter amyloid-β peptide aggregation that they hope could be used to find new treatments for Alzheimer’s disease. Research into Alzheimer’s disease has shown that the self-aggregation o ... more

    Moving the MRI goalposts

    Scientists in the UK have developed a new class of MRI (magnetic resonance imaging) agents that promise to deliver clearer images more quickly. Chemical shifts from proton NMR normally fall between 0-12ppm, but water and fat resonate at 4.7 and 1.3ppm respectively, causing noise that can ov ... more

    High-throughput drug screening in 3D

    Scientists in China have developed a simple microchip that enables quick and inexpensive high-throughput screening of potential drug candidates in 3D cell cultures. Scientists often use cell-based high-throughput screening in the first stage of drug design as a technique to quickly identify ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE